Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy

Journal of Medical Virology

Volumn 74, Issue 3, 2004, Pages 406-413

  Tsuda, Natsuko ^a   Yuki, Nobukazu ^a   Mochizuki, Kiyoshi ^b   Nagaoka, Takayuki ^c   Yamashiro, Masatoshi ^c   Omura, Masao ^c   Hikiji, Kazumasa ^c   Kato, Michio ^a  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SRL INC   (Japan)

Author keywords

Hepatocellular carcinoma; Occult HBV infection; Occult HCV infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2A INTERFERON; BETA INTERFERON; INTERFERON; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CLEARANCE; DNA SEQUENCE; FEMALE; FOLLOW UP; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER HISTOLOGY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT MONITORING; RISK ASSESSMENT; RNA SEQUENCE; TREATMENT OUTCOME;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RNA, VIRAL;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 4644224871     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20190     Document Type: Article

References (22)

1. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M, Kohara M. 1999. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 37:2899-2903.
2. Bruno S, Battezzati PM, Bellati G, Manzin A, Maggioni M, Crosignani A, Borzio M, Solforosi L, Morabito A, Ideo G, Podda M. 2001. Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. J Hepatol 34:748-755.
3. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. 1999. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341:22-26.
4. Dries V, von Both I, Müller M, Gerken G, Schirmacher P, Odenthal M, Bartenschlager R, Drebber U, zum Büschenfelde K-HM, Dienes HP. 1999. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 29:223-229.
5. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T. 1993. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 104:877-883.
6. Haydon GH, Jarvis LM, Blair CS, Simmonds P, Harrison DJ, Simpson KJ, Hayes PC. 1998. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut 42: 570-575.
7. Imai Y, Kawata S, Tamura S, Yabuuchi I, Noda S, Inada M, Maeda Y, Shirai Y, Fukuzaki T, Kaji I, Ishikawa H, Matsuda Y, Nishikawa M, Seki K, Matsuzawa Y. 1998. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Ann Intern Med 129:94-99.
8. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H. 1995. Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699.
9. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
10. Lau DT-Y, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 1998. 10-Year follow-up after interferon-α therapy for chronic hepatitis C. Hepatology 28:1121-1127.
11. Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S. 1997. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy. Ann Intern Med 127: 875-881.
12. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling M-H, Cort S, Albrecht JK. 1998. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339:1485-1492.
13. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J. 1998. Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 352:1426-1432.
14. Pradat P, Alberti A, Poynard T, Esteban J-I, Weiland O, Marcellin P, Badalamenti S, Trépo C. 2002. Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study. Hepatology 36:973-977.
15. Reichard O, Glaumann H, Frydén A, Norkrans G, Schvarcz R, Sönnerborg A, Yun Z-B, Weiland O. 1995. Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 21:918-922.
16. Shindo M, Arai K, Sokawa Y, Okuno T. 1995. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-α therapy. Ann Intern Med 122:586-591.
17. Shindo M, Hamada K, Oda Y, Okuno T. 2001. Long-term follow-up study of sustained biochemical responders with interferon therapy. Hepatology 33:1299-1302.
18. Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, Kuroki T, Nishiguchi S, Sata M, Yamada G, Fujiyama S, Yoshida H, Omata M. 2000. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 132:517-524.
19. Sugiyasu Y, Yuki N, Nagaoka T, Yamashiro M, Kawahara K, Iyoda K, Kakiuchi Y, Kaneko A, Yamamoto K, Hikiji K, Kato M. 2003. Histological improvement of chronic liver disease after spontaneous serum hepatitis C virus clearance. J Med Virol 69:41-49.
20. Tamori A, Nishiguchi S, Kubo S, Koh N, Moriyama Y, Fujimoto S, Takeda T, Shiomi S, Hirohashi K, Kinoshita H, Otani S, Kuroki T. 1999. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus. Hepatology 29:1429-1434.
21. Tomimatsu M, Endou H, Takahashi H, Iga D, Kato Y, Tamai N, Nakajima H, Okano A, Mori H, Hisatomi H. 1997. Negative strand of hepatitis C virus RNA in the liver of patients with chronic hepatitis C after interferon treatment. J Gastroenterol Hepatol 12: 629-632.
22. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Inoue O, Yano M, Tanaka M, Fujiyama S, Nishiguchi S, Kuroki T, Imazeki F, Yokosuka O, Kinoyama S, Yamada G, Omata M. 1999. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 131: 174-181.